Explore more publications!

Fiji Tech Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Fiji Tech Network.

Press releases published on April 13, 2026

Ministers and Members of Parliament at Paris Blockchain Week 2026: A Historic Signal for the Institutionalization of Crypto-Assets
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
3D Systems Accelerates Production-Scale Additive Manufacturing with New High-Throughput Platform and Next-Generation Factory Software
Gelatide Drops Investigated (2026 Report) What Consumers Should Verify Before Buying
From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture
Eclipse Life Sciences Completes Enrollment in Phase 2 Study Evaluating EC-104 for Diabetic Macular Edema (DME)
Aeluma Secures More Than $4 Million in Contracts for Quantum Materials and Lasers
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Appointment of Glenn Tyson as the Company’s first Chief Commercial Officer
Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma
Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
ImageneBio Announces $30 Million Private Placement
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Leanzene Gummies Examined: 2026 Consumer-Focused Breakdown of Ingredients, Claims & Label Transparency
OFFENTLIGGØRELSE AF DET ENDELIGE RESULTAT FOR FREUDENBERGS OFFENTLIGE OVERTAGELSESTILBUD TIL AKTIONÆRERNE I NILFISK HOLDING A/S
ANNOUNCEMENT OF THE FINAL RESULT OF FREUDENBERG’S PUBLIC TAKEOVER OFFER TO THE SHAREHOLDERS OF NILFISK HOLDING A/S
Regeneron and Telix Announce Strategic Radiopharma Collaboration

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions